Denali Therapeutics Inc (DNLI)
18.31
-0.36
(-1.93%)
USD |
NASDAQ |
May 10, 16:00
18.30
-0.01
(-0.05%)
After-Hours: 20:00
Denali Therapeutics 1 Year Total Returns (Daily): -35.46% for May 10, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 10, 2024 | -35.46% |
May 09, 2024 | -31.66% |
May 08, 2024 | -28.84% |
May 07, 2024 | -36.46% |
May 06, 2024 | -35.37% |
May 03, 2024 | -33.72% |
May 02, 2024 | -31.05% |
May 01, 2024 | -37.36% |
April 30, 2024 | -37.84% |
April 29, 2024 | -37.20% |
April 26, 2024 | -36.68% |
April 25, 2024 | -37.38% |
April 24, 2024 | -37.64% |
April 23, 2024 | -35.87% |
April 22, 2024 | -36.35% |
April 19, 2024 | -35.95% |
April 18, 2024 | -33.92% |
April 17, 2024 | -34.14% |
April 16, 2024 | -29.83% |
April 15, 2024 | -27.80% |
April 12, 2024 | -24.33% |
April 11, 2024 | -19.59% |
April 10, 2024 | -23.47% |
April 09, 2024 | -19.93% |
April 08, 2024 | -21.58% |
Date | Value |
---|---|
April 05, 2024 | -19.58% |
April 04, 2024 | -19.74% |
April 03, 2024 | -17.12% |
April 02, 2024 | -15.89% |
April 01, 2024 | -10.76% |
March 28, 2024 | -10.08% |
March 27, 2024 | -10.74% |
March 26, 2024 | -13.19% |
March 25, 2024 | -13.23% |
March 22, 2024 | -13.11% |
March 21, 2024 | -9.72% |
March 20, 2024 | -8.74% |
March 19, 2024 | -11.96% |
March 18, 2024 | -13.89% |
March 15, 2024 | -15.49% |
March 14, 2024 | -16.21% |
March 13, 2024 | -10.91% |
March 12, 2024 | -10.55% |
March 11, 2024 | -6.59% |
March 08, 2024 | -18.72% |
March 07, 2024 | -21.25% |
March 06, 2024 | -24.45% |
March 05, 2024 | -26.47% |
March 04, 2024 | -25.71% |
March 01, 2024 | -23.59% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-71.45%
Minimum
Jun 14 2022
395.9%
Maximum
Dec 30 2020
26.16%
Average
-10.78%
Median
Apr 23 2020
1 Year Total Returns (Daily) Benchmarks
Halozyme Therapeutics Inc | 25.11% |
AIM ImmunoTech Inc | -14.88% |
Perspective Therapeutics Inc | 169.2% |
Protalix BioTherapeutics Inc | -62.58% |
Armata Pharmaceuticals Inc | 129.0% |